Ares Financial Consulting’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.6K Buy
187
+21
+13% +$1.4K 0.01% 520
2026
Q1
$10.4K Buy
166
+50
+43% +$3.48K 0.01% 535
2025
Q4
$7.7K Buy
+116
New +$7.5K 0.01% 397

Other funds holding DXCM

Ares Financial Consulting's DXCM Position: Q2 2026 in Review

Ares Financial Consulting increased its DexCom (DXCM) stake by 13% in Q2 2026, buying an estimated $1.4K and bringing the position to 187 shares worth $12.6K. The position accounts for 0.01% of the portfolio, ranked #520.

Ares Financial Consulting first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 463 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Ares Financial Consulting held 187 shares of DexCom worth $12.6K as of Q2 2026.
  • Ares Financial Consulting bought 21 DexCom shares in Q2 2026, an estimated $1.4K.
  • DexCom made up 0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #520 holding.
  • Ares Financial Consulting first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • 463 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.